Home › Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
 

Keywords :   


Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial

2014-06-11 16:23:49| Biotech - Topix.net

Encouraging single-agent CYRAMZA activity was observed, with meaningful improvements in key secondary endpoints of progression-free survival, overall response rate and time to progression.

Tags: results iii trial phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
15.05Royal Mail owner poised to accept 3.5bn takeover bid
15.05Gold Bond Named Official Body Skin Sponsor of Sports Illustrated Swimsuit\'s 60th Anniversary Issue
15.05Dunn-Edwards Reveals New Multifamily Color Collection
15.05Kimberly-Clark Names Chief Growth Officer
More »